These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 37180996)

  • 21. Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study.
    de Wolf F; Ghanbari M; Licher S; McRae-McKee K; Gras L; Weverling GJ; Wermeling P; Sedaghat S; Ikram MK; Waziry R; Koudstaal W; Klap J; Kostense S; Hofman A; Anderson R; Goudsmit J; Ikram MA
    Brain; 2020 Apr; 143(4):1220-1232. PubMed ID: 32206776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease.
    Jackson RJ; Rudinskiy N; Herrmann AG; Croft S; Kim JM; Petrova V; Ramos-Rodriguez JJ; Pitstick R; Wegmann S; Garcia-Alloza M; Carlson GA; Hyman BT; Spires-Jones TL
    Eur J Neurosci; 2016 Dec; 44(12):3056-3066. PubMed ID: 27748574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sex differences in plasma p-tau181 associations with Alzheimer's disease biomarkers, cognitive decline, and clinical progression.
    Tsiknia AA; Edland SD; Sundermann EE; Reas ET; Brewer JB; Galasko D; Banks SJ;
    Mol Psychiatry; 2022 Oct; 27(10):4314-4322. PubMed ID: 35768637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies.
    Ferrer I; Gomez-Isla T; Puig B; Freixes M; Ribé E; Dalfó E; Avila J
    Curr Alzheimer Res; 2005 Jan; 2(1):3-18. PubMed ID: 15977985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma biomarkers predict amyloid pathology in cognitively normal monozygotic twins after 10 years.
    den Braber A; Verberk IMW; Tomassen J; den Dulk B; Stoops E; Dage JL; Collij LE; Barkhof F; Willemsen G; Nivard MG; van Berckel BNM; Scheltens P; Visser PJ; de Geus EJC; Teunissen CE
    Brain Commun; 2023; 5(1):fcad024. PubMed ID: 36824390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.
    Benedet AL; Leuzy A; Pascoal TA; Ashton NJ; Mathotaarachchi S; Savard M; Therriault J; Kang MS; Chamoun M; Schöll M; Zimmer ER; Gauthier S; Labbe A; Zetterberg H; Rosa-Neto P; Blennow K;
    Brain; 2020 Dec; 143(12):3793-3804. PubMed ID: 33210117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PTI-125 Reduces Biomarkers of Alzheimer's Disease in Patients.
    Wang HY; Pei Z; Lee KC; Lopez-Brignoni E; Nikolov B; Crowley CA; Marsman MR; Barbier R; Friedmann N; Burns LH
    J Prev Alzheimers Dis; 2020; 7(4):256-264. PubMed ID: 32920628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alzheimer's Disease and Cognitive Decline in Patients with Cardiovascular Diseases Along the Heart-Brain Axis.
    Trieu C; van Harten AC; Leeuwis AE; Exalto LG; Hooghiemstra AM; Verberk IMW; Allaart CP; Brunner-La Rocca HP; Kappelle LJ; van Oostenbrugge RJ; Biessels GJ; Teunissen CE; van der Flier WM;
    J Alzheimers Dis; 2024; 98(3):987-1000. PubMed ID: 38489178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ante-mortem plasma phosphorylated tau (181) predicts Alzheimer's disease neuropathology and regional tau at autopsy.
    Morrison MS; Aparicio HJ; Blennow K; Zetterberg H; Ashton NJ; Karikari TK; Tripodis Y; Martin B; Palmisano JN; Sugarman MA; Frank B; Steinberg EG; Turk KW; Budson AE; Au R; Goldstein LE; Jun GR; Kowall NW; Killiany R; Qiu WQ; Stern RA; Mez J; McKee AC; Stein TD; Alosco ML
    Brain; 2022 Oct; 145(10):3546-3557. PubMed ID: 35554506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma markers predict changes in amyloid, tau, atrophy and cognition in non-demented subjects.
    Pereira JB; Janelidze S; Stomrud E; Palmqvist S; van Westen D; Dage JL; Mattsson-Carlgren N; Hansson O
    Brain; 2021 Oct; 144(9):2826-2836. PubMed ID: 34077494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I; Barrachina M; Puig B
    Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline.
    Koss DJ; Jones G; Cranston A; Gardner H; Kanaan NM; Platt B
    Acta Neuropathol; 2016 Dec; 132(6):875-895. PubMed ID: 27770234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beneficial effect of human anti-amyloid-beta active immunization on neurite morphology and tau pathology.
    Serrano-Pozo A; William CM; Ferrer I; Uro-Coste E; Delisle MB; Maurage CA; Hock C; Nitsch RM; Masliah E; Growdon JH; Frosch MP; Hyman BT
    Brain; 2010 May; 133(Pt 5):1312-27. PubMed ID: 20360050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurofilament light as a biomarker of axonal degeneration in patients with mild cognitive impairment and Alzheimer's disease.
    Chen Y; Therriault J; Luo J; Ba M; Zhang H; Initiative ADN
    J Integr Neurosci; 2021 Dec; 20(4):861-870. PubMed ID: 34997710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship of plasma biomarkers to digital cognitive tests in Alzheimer's disease.
    Toniolo S; Zhao S; Scholcz A; Amein B; Ganse-Dumrath A; Heslegrave AJ; Thompson S; Manohar S; Zetterberg H; Husain M
    Alzheimers Dement (Amst); 2024; 16(2):e12590. PubMed ID: 38623387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synaptic resilience is associated with maintained cognition during ageing.
    King D; Holt K; Toombs J; He X; Dando O; Okely JA; Tzioras M; Rose J; Gunn C; Correia A; Montero C; McAlister H; Tulloch J; Lamont D; Taylor AM; Harris SE; Redmond P; Cox SR; Henstridge CM; Deary IJ; Smith C; Spires-Jones TL
    Alzheimers Dement; 2023 Jun; 19(6):2560-2574. PubMed ID: 36547260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plaque biogenesis in brain aging and Alzheimer's disease. II. Progressive transformation and developmental sequence of dystrophic neurites.
    Su JH; Cummings BJ; Cotman CW
    Acta Neuropathol; 1998 Nov; 96(5):463-71. PubMed ID: 9829809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Downregulation of Dickkopf-3, a Wnt antagonist elevated in Alzheimer's disease, restores synapse integrity and memory in a disease mouse model.
    Martin Flores N; Podpolny M; McLeod F; Workman I; Crawford K; Ivanov D; Leonenko G; Escott-Price V; Salinas PC
    Elife; 2024 Jan; 12():. PubMed ID: 38285009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.
    Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Li QX; Ames D; Masters CL; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM;
    J Alzheimers Dis; 2018; 66(3):1193-1211. PubMed ID: 30412495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polygenic hazard score: an enrichment marker for Alzheimer's associated amyloid and tau deposition.
    Tan CH; Fan CC; Mormino EC; Sugrue LP; Broce IJ; Hess CP; Dillon WP; Bonham LW; Yokoyama JS; Karch CM; Brewer JB; Rabinovici GD; Miller BL; Schellenberg GD; Kauppi K; Feldman HA; Holland D; McEvoy LK; Hyman BT; Bennett DA; Andreassen OA; Dale AM; Desikan RS;
    Acta Neuropathol; 2018 Jan; 135(1):85-93. PubMed ID: 29177679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.